关于增加注册资本完成工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 山东瑞丰高分子材料股份有限公司 山东瑞丰高分子材料股份有限公司（以下简称"公司"）分别于 2023 年 7 月 4 日、2023 年 7 月 24 日召开第五届董事会第十一次会议、2023 年第二次临时 股东大会审议通过了《关于变更注册资本并修订<公司章程>的议案》，根据公司 实收股本变化情况，需增加公司注册资本，同时对《公司章程》中相关条款进行 修订。以上具体内容详见公司在巨潮资讯网（www.cninfo.com.cn）披露的相关内 容（公告编号：2023-045）。 公司于 2023 年 8 月 8 日完成了工商变更登记及《公司章程》备案相关手续， 取得了由淄博市行政审批服务局核发的《营业执照》，相关登记信息如下： | 证券代码：300243 | 证券简称：瑞丰高材 | 公告编号：2023-055 | | --- | --- | --- | | 债券代码：123126 | 债券简称：瑞丰转债 | | 5、注册资本：贰亿叁仟伍佰肆拾陆万叁仟叁佰零伍元整 6、成立日期：20 ...

证券代码：300243 证券简称：瑞丰高材 山东瑞丰高分子材料股份有限公司 投资者关系活动记录表 | --- | --- | --- | |----------------|-----------------------|-----------| | | ☑ | | | | □媒体采访 □业绩说明会 | | | 投资者关系活动 | | | | | □新闻发布会 | □路演活动 | | 类别 | | | | | □现场参观 | | □其他 时间、方式、参 与机构名称 2023 年 7 月 28 日，华夏基金张俊、兴业证券张勋、兴业证券赵 晓昂 地点 山东省沂源县经济开发区公司四楼会议室 上市公司接待人 员姓名 董事会秘书赵子阳；证券事务代表朱西海 1、公司产能的情况 MBS 抗冲改性剂 7 万吨，ACR 加工助剂和抗冲改性剂 7 万吨，MC 抗冲改性剂 4 万吨，合计 18 万吨。另外，为了继续提升 ACR 的行业地位， 公司于去年技术改建 1.6 万吨 ACR，即将于今年 8 月投产。 2、公司产品的下游应用情况 投资者关系活动 公司塑料助剂主要应用于 PVC 制品，如管材型材、地板墙板、发泡 主要内容介绍 ...

| 衡，产品价格有所降低，收入和毛利额有所降低。谢谢！ | | | --- | --- | | 4、股票价格现在用脚踹！说明企业没经营好？今后采取什么措 | | | 施提高企业业绩？ | | | 你好！2022 年经营情况请查看公司 2022 年度报告中"管理层讨 | | | 论与分析"章节。下一步，一方面，继续夯实公司原主营业务，保持 | | | 市场份额稳中有升，另一方面，紧跟行业政策，积极组织好几个在 | | | 建项目的实施，早日发挥效益。谢谢！ | | | 5、公司的 PBAT 项目一期已经完工，迟迟不开工，董秘回复是 | | | 公司一直认为下游需求情况不明朗。结合目前 PBAT | 产能严重过剩， | | 请问公司是否承认该项目决策失误，现在开工即亏钱，未来可能 | | | 价格更低，公司的产能投入是否有打水漂的可能？ PBAT | | | 你好！解决"白色污染"问题的有效途径之一，是使用可降解塑 | | | 料制品。当前受制于上下游产业链不配套及禁塑政策实施低于预期， | | | 可降解材料市场暂时面临一些压力。公司 PBAT 项目是一套聚酯装 | | | 置，除可以满足 产品生产外，还可满足 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥410,808,987.33, a decrease of 18.04% compared to ¥501,228,023.58 in the same period last year[6] - Net profit attributable to shareholders was ¥17,683,765.50, down 43.67% from ¥31,394,431.21 year-on-year[6] - Basic earnings per share decreased by 42.86% to ¥0.08 from ¥0.14 in the same period last year[6] - Total operating revenue for Q1 2023 was CNY 410,808,987.33, a decrease of 18.0% compared to CNY 501,228,023.58 in Q1 2022[20] - Net profit for Q1 2023 was CNY 17,683,765.50, representing a decline of 43.8% from CNY 31,394,431.21 in Q1 2022[21] - Basic earnings per share for Q1 2023 were CNY 0.08, down from CNY 0.14 in Q1 2022[22] Cash Flow - The net cash flow from operating activities improved to -¥41,475,544.99, a 54.40% increase compared to -¥90,964,610.07 in the previous year[6] - Cash flow from operating activities for Q1 2023 showed a net outflow of CNY 41,475,544.99, an improvement from a net outflow of CNY 90,964,610.07 in Q1 2022[23] - The net cash flow from financing activities significantly increased by 1679.19% to ¥66,816,552.06, up from ¥3,755,450.89 in the same period last year[10] - Cash inflow from financing activities totaled 139,300,000.00, an increase from 117,500,000.00 year-over-year[25] - The net cash flow from financing activities was 66,816,552.06, significantly higher than 3,755,450.89 in the same period last year[25] - The net cash flow from investment activities was -28,690,044.52, compared to -5,212,669.71 in the previous year[25] Assets and Liabilities - Total assets increased by 3.43% to ¥2,008,137,515.92 from ¥1,941,503,163.88 at the end of the previous year[6] - The company reported a significant increase in non-current liabilities due within one year, rising by 67.25% to ¥115,400,000.00 from ¥69,000,000.00[10] - The total liabilities as of Q1 2023 were CNY 1,054,134,571.14, an increase from CNY 1,006,009,276.05 in Q1 2022[18] - The total equity attributable to shareholders of the parent company was CNY 954,002,944.78, up from CNY 935,493,887.83 in the previous year[18] Shareholder Information - Total number of common shareholders at the end of the reporting period is 16,930[12] - The largest shareholder, Zhou Shibin, holds 22.28% of shares, totaling 51,752,197 shares[12] Research and Development - Research and development expenses rose by 35.46% to ¥1,174,232.85 compared to ¥866,834.70 in the previous year[10] - Research and development expenses increased to CNY 1,174,232.85 in Q1 2023, up from CNY 866,834.70 in Q1 2022, indicating a focus on innovation[20] Other Financial Metrics - The company's weighted average return on equity decreased to 1.84% from 3.45% year-on-year[6] - The company received government subsidies amounting to ¥527,673.57 during the reporting period, which is a decrease of 57.84% compared to the previous year[10] - The company reported a decrease in other income to CNY 527,673.57 in Q1 2023 from CNY 1,251,557.70 in Q1 2022, indicating potential challenges in ancillary revenue streams[21] Current Assets and Liabilities - The company’s total current assets amount to 985,233,433.10 CNY, an increase from 947,485,102.13 CNY at the beginning of the year[17] - Total current liabilities increased to 693,928,165.57 CNY from 622,779,315.62 CNY[17] - Cash and cash equivalents decreased to 169,897,990.13 CNY from 186,050,514.28 CNY[15] - Accounts receivable increased to 326,802,688.34 CNY from 292,807,449.02 CNY[15] - Inventory increased to 254,270,511.48 CNY from 203,099,658.77 CNY[15] - The total non-current assets amount to 1,022,904,082.82 CNY, an increase from 994,018,061.75 CNY[17] Audit Information - The company did not undergo an audit for the first quarter report[26]

Financial Performance - The company's operating revenue for 2022 was approximately ¥1.83 billion, a decrease of 1.45% compared to ¥1.86 billion in 2021[30]. - The net profit attributable to shareholders for 2022 was approximately ¥61.14 million, down 34.17% from ¥92.87 million in 2021[30]. - The net profit after deducting non-recurring gains and losses was approximately ¥47.03 million, a decline of 55.70% compared to ¥106.17 million in 2021[30]. - The net cash flow from operating activities was negative at approximately -¥8.62 million, a decrease of 107.76% from ¥111.14 million in 2021[30]. - The total assets at the end of 2022 were approximately ¥1.94 billion, an increase of 15.00% from ¥1.69 billion at the end of 2021[30]. - The net assets attributable to shareholders at the end of 2022 were approximately ¥935.49 million, up 4.64% from ¥894.04 million at the end of 2021[30]. - The basic earnings per share for 2022 were ¥0.26, a decrease of 35.00% from ¥0.40 in 2021[30]. - The diluted earnings per share for 2022 were ¥0.27, down 30.77% from ¥0.39 in 2021[30]. - The weighted average return on equity for 2022 was 6.70%, a decrease of 4.95% from 11.65% in 2021[30]. Production Capacity and Projects - The company is currently constructing several projects, including a 60,000-ton biodegradable polymer PBAT project and a 20,000-ton epoxy chloropropane project, which are nearing trial production[11]. - The company has increased its production capacity by 40,000 tons in recent years, which may lead to intensified competition in the ACR product market[10]. - The company has a comprehensive production capacity of 180,000 tons, with ACR products having an annual capacity of 70,000 tons, MBS impact modifiers also at 70,000 tons, and MC impact modifiers at 40,000 tons[41]. - The company is expanding into the engineering plastic additives sector, achieving a production capacity of 30,000 tons per year for engineering plastic additives through technical upgrades of existing MBS production lines[44]. - The company is preparing for trial production of a 60,000-ton biodegradable PBAT project, which is significantly influenced by the price fluctuations of BDO and related market policies[53]. Market and Competition - The company plans to expand its product offerings to include engineering plastic additives and biodegradable materials, although these new products may face market competition and demand uncertainties[13]. - The company aims to enhance its market share in the ACR sector through technological innovation and product optimization, while also striving to improve product quality in the MBS sector to compete with foreign enterprises[42]. - The PVC additives industry is in a mature development stage, with increasing market share concentration among leading companies due to stricter environmental regulations[42]. - The company has achieved breakthroughs in the research and development of new products such as ASA and ABS high rubber powder, entering new market segments[30]. - The company is focusing on expanding its engineering plastic additives business, which currently has a small market share but is a key area for growth[52]. Financial Management and Investments - The company will not distribute cash dividends, issue bonus shares, or increase share capital from reserves[15]. - The company reported a government subsidy of ¥2.36 million in 2022, which is closely related to its normal business operations[35]. - The company has conducted thorough feasibility studies for its investment projects, but acknowledges the risk of not achieving expected returns due to market or policy changes[11]. - The company has a dedicated legal department to manage accounts receivable and reduce bad debt risks through various collection measures[123]. - The company has established a special account for raised funds[166]. Research and Development - Research and development expenses increased by 49.22% to ¥6,432,838.58, reflecting increased investment in R&D activities[84]. - The company is developing high-toughness and high-transparency MBS resin to meet diverse customer needs, which is expected to enhance market influence[86]. - The company is also focusing on the development of PBAT polyester high-filling and high-melt-strength agents to align with national environmental policies and expand its market presence[86]. - The company has successfully completed pilot tests for PLA biodegradable materials, positioning itself to meet the growing demand for environmentally friendly products[45]. Risk Management - The company acknowledges potential risks from macroeconomic conditions, including the impact of the real estate market on customer demand[14]. - The company has implemented measures to mitigate raw material price fluctuations, including diversifying procurement channels and adjusting sales prices based on raw material costs[6]. - The company emphasizes strict safety management and environmental compliance to mitigate risks associated with hazardous materials used in production[9]. - The company is closely monitoring the macroeconomic environment, including the impact of the domestic real estate market on customer demand, to adjust its operational strategies accordingly[130]. Corporate Governance - The company has maintained a consistent leadership team with no reported changes in directors or senior management during the reporting period[148]. - The board includes independent directors, ensuring governance and oversight in decision-making processes[149]. - The company has established a comprehensive corporate governance system in accordance with regulatory requirements[199]. - The audit committee held five meetings during the reporting period, reviewing various internal audit reports and financial statements[171]. Shareholder Relations - The company reported a 26.50% investor participation rate in the 2021 annual general meeting held on June 13, 2022[145]. - The company proposed no cash dividends, no bonus shares, and no capital reserve conversion to share capital for the 2022 fiscal year, despite having a positive distributable profit of RMB 415,502,486.59[185]. - The company emphasizes the importance of protecting minority shareholders' rights and ensuring transparency in its profit distribution policies[182]. - The company plans to continue prioritizing cash dividends in accordance with relevant laws and regulations, while focusing on long-term shareholder value[186].

山东瑞丰高分子材料股份有限公司 关于举行 2022 年度报告业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 | 证券代码：300243 | 证券简称：瑞丰高材 公告编号：2023-024 | | --- | --- | | 债券代码：123126 | 债券简称：瑞丰转债 | 山东瑞丰高分子材料股份有限公司（以下简称"公司"）已于 2023 年 4 月 18 日在巨潮资讯网（www.cninfo.com.cn）披露了公司 2022 年度报告。为便于广 大投资者更深入全面地了解公司情况，公司定于 2023 年 4 月 27 日（星期四） 15:00～17:00 举行 2022 年度业绩说明会，本次年度业绩说明会将采用网络远程 方式举行，投资者可以登录全景网"投资者关系互动平台"（http://ir.p5w.net）参 与本次年度业绩说明会。 出席本次年度业绩说明会的人员如下：董事长周仕斌先生，董事、总经理刘 春信先生，财务总监许曰玲女士，董事会秘书赵子阳先生，独立董事董华先生。 为充分尊重投资者、提升交流的针对性，现就公司 2022 年度业绩说明 ...

Group 1: Company Performance - The company achieved revenue and profit growth in 2014 despite a challenging economic environment [1] - The first quarter of 2015 saw significant performance improvement, attributed to product innovation and cost advantages from low raw material prices [2] Group 2: MBS Product Insights - MBS product is used in consumer applications like packaging materials and has a high technical barrier, limiting competition [2] - The global market capacity for MBS is approximately 300,000 tons, with a domestic capacity of about 70,000 tons; the company currently has a production capacity of 20,000 tons, expanding to 30,000 tons [3] - The company's market share in the domestic MBS market exceeds 45%, with over 30,000 tons being imported [3] Group 3: ACR Product Overview - ACR products are in a competitive market with relatively low technical barriers, but have maintained stable development due to growth in related industries [4] Group 4: Raw Material Pricing and Risks - The price of butadiene is now comparable to international prices, eliminating previous advantages [4] - The company faces risks from anti-dumping measures on methyl methacrylate, but these impacts have been mitigated [4] Group 5: Future Growth Strategies - The company plans to combine internal growth with external expansion, focusing on shareholder interests and utilizing capital markets for financing [5] - A non-public offering is being prepared to support the development of supply chain financial services [5]

证券代码：300243 证券简称：瑞丰高材 山东瑞丰高分子材料股份有限公司 投资者关系活动记录表 编号：20150428 | --- | --- | --- | |--------------|-------------------------|----------------------------------------------------------| | | | | | | | ■特定对象调研 □分析师会议 | | | □媒体采访 □业绩说明会 | | | 投资者关系活 | □ | 新闻发布会 □路演活动 | | 动类别 | □现场参观 | | | | □ 其他 | | | | | 富国基金宋哲建、国泰君安任浪、国泰君安周新明、银河证券胡 | | | | 昂、平安证券罗晓娟、平安证券缴文超、平安证券蒲强、齐鲁证 | | 参与单位及人 | | 券刘强、信达证券王光兵、信达证券谢从军、浙江中大集团投资 | | 员姓名 | | 有限公司张晓晓、广州赢隆投资管理有限公司倪国柱、深圳硅 | | | | 谷昭华资产管理公司江崇义、国信证券苏淼 | | 时间 | 2015 年 4 月 28 | 日 | | 地点 ...

证券代码：300243 证券简称：瑞丰高材 山东瑞丰高分子材料股份有限公司 投资者关系活动记录表 编号：20161222 | --- | --- | --- | |-----------------------|--------------------------|--------------------------------------------------------| | | | | | | | ■特定对象调研 □分析师会议 | | | □媒体采访 □业绩说明会 | | | 投资者关系活 | □ 新闻发布会 □路演活动 | | | 动类别 | □现场参观 | | | | □ 其他 | | | 参与单位及人 | 海通证券股份有限公司 | -- 刘强 | | 员姓名 | | | | 时间 地点 | 2016 年 12 月 22 | 日 山东省沂源县经济开发区东岭路公司董秘办公室 | | | | | | 上市公司接待 人员姓名 | | 董事会秘书赵子阳,副总经理刘春信,证券事务专员朱西海 | | 投资者关系活 | 1 | 、简单介绍下本次交易的背景？ | | 动主要内容介 | | | | 绍 | | （1 ...

证券代码：300243 证券简称：瑞丰高材 山东瑞丰高分子材料股份有限公司 投资者关系活动记录表 编号：20180517 | --- | --- | --- | |--------------|-------------------------|----------------------------------------------------------| | | | | | | | ■特定对象调研 □分析师会议 | | | □媒体采访 □业绩说明会 | | | 投资者关系活 | □ 新闻发布会 □路演活动 | | | 动类别 | □现场参观 | | | | □ 其他 | | | | | 财通证券张兴宇、财通证券虞小波、中金公司李璇、天风证券陈 | | 参与单位及人 | | 宏亮、海通证券刘威、西南证券段海峰、广发证券邹戈、新时代 | | | | 证券程磊、东吴证券柴沁虎、国投瑞银基金周思捷、农银汇理基 | | 员姓名 | | 金陆震、银河基金张瑞、华宝基金王天乐、华宝基金胡日新、东 | | | 吴基金吴昌柏 | | | 时间 | 2018 年 5 月 17 | 日 | | 地点 | 上海市浦东新区正大 ...